CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on understanding the role of regulatory T cells in maintaining immune balance and their potential in cancer treatment. It aims to characterize tissue-resident Tregs and develop strategies to modulate their function for therapeutic purposes.
The immune system with its complex interactions of cells and molecules needs a very tight and specific interplay of control elements to ensure the establishment and re-establishment of immune homeostasis after challenges.
Regulatory T cells (Tregs) are key-players in this regulatory network.
It is now well accepted that deficiency or dysfunction of Tregs causes various severe immune disorders due to immune hyperactivation.
Conversely, an increased number of Tregs in tumor-bearing individuals sup…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Heidelberg
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
